Novanta to Present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025
Novanta (Nasdaq: NOVT), a technology partner specializing in medical and advanced technology equipment manufacturing, has announced its participation in the J.P. Morgan 43rd Annual Healthcare Conference. The presentation will take place on January 13, 2025, in San Francisco, California. The company will be represented by Chair & CEO Matthijs Glastra and CFO Robert Buckley at this prestigious healthcare industry event.
Novanta (Nasdaq: NOVT), un partner tecnologico specializzato nella produzione di attrezzature mediche e tecnologiche avanzate, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale sulla Salute di J.P. Morgan. La presentazione si svolgerà il 13 gennaio 2025 a San Francisco, California. L'azienda sarà rappresentata dal Presidente e CEO Matthijs Glastra e dal CFO Robert Buckley in questo prestigioso evento del settore sanitario.
Novanta (Nasdaq: NOVT), un socio tecnológico especializado en la fabricación de equipos médicos y de tecnología avanzada, ha anunciado su participación en la 43.ª Conferencia Anual de Salud de J.P. Morgan. La presentación tendrá lugar el 13 de enero de 2025 en San Francisco, California. La empresa estará representada por el Presidente y CEO Matthijs Glastra y el CFO Robert Buckley en este prestigioso evento de la industria de la salud.
노반타 (Nasdaq: NOVT)는 의료 및 첨단 기술 장비 제조를 전문으로 하는 기술 파트너로, JP 모건 제43회 연례 의료 회의에 참여한다고 발표했습니다. 발표는 2025년 1월 13일 캘리포니아 샌프란시스코에서 진행될 예정입니다. 이 회사는 이 유명한 헬스케어 산업 행사에서 회장 겸 CEO인 Matthijs Glastra와 CFO인 Robert Buckley가 대표합니다.
Novanta (Nasdaq: NOVT), un partenaire technologique spécialisé dans la fabrication d'équipements médicaux et de technologie avancée, a annoncé sa participation à la 43e Conférence Annuelle sur la Santé de J.P. Morgan. La présentation aura lieu le 13 janvier 2025 à San Francisco, Californie. L'entreprise sera représentée par le Président et CEO Matthijs Glastra et le CFO Robert Buckley lors de cet événement prestigieux de l'industrie de la santé.
Novanta (Nasdaq: NOVT), ein Technologiepartner, der auf die Herstellung von medizinischen und fortschrittlichen Technologiegeräten spezialisiert ist, hat seine Teilnahme an der 43. J.P. Morgan Jahrestagung für Gesundheitswesen bekannt gegeben. Die Präsentation findet am 13. Januar 2025 in San Francisco, Kalifornien, statt. Das Unternehmen wird bei dieser renommierten Veranstaltung der Gesundheitsbranche von Chairman und CEO Matthijs Glastra sowie CFO Robert Buckley vertreten.
- None.
- None.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”
More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241218710435/en/
Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137
Source: Novanta Inc.
FAQ
When is Novanta (NOVT) presenting at the J.P. Morgan Healthcare Conference 2025?
Who will represent Novanta (NOVT) at the 2025 J.P. Morgan Healthcare Conference?
Which healthcare conference will Novanta (NOVT) attend in January 2025?
What type of technology partner is Novanta (NOVT)?
